Bile duct cancer and intestinal bacteria

Characteristics and role of intestinal flora in the development of biliary tract cancer and the efficacy of chemotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030240555

Enrollment

Registered

2024-12-16

Start date

2024-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary tract cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients who are 40 years of age or older at the time of obtaining consent 2) Patients who have been diagnosed with biliary tract cancer and are scheduled to undergo chemotherapy 3) Patients who have been fully informed of the details of this study and have given their written consent freely and of their own accord after fully understanding the details of the study

Exclusion criteria

Exclusion criteria: 1) Patients who the principal investigator deems unsuitable as research subjects 2) Patients who have refused to participate in this study

Design outcomes

Primary

Measure	Time frame
Intestinal flora characteristic of patients with biliary tract cancer	—

Secondary

Measure	Time frame
Relationship between changes in intestinal flora before and after biliary tract cancer chemotherapy and chemotherapy efficacy Relationship between changes in intestinal flora before and after biliary tract cancer chemotherapy and side effect profile Relationship between intestinal flora before biliary tract cancer chemotherapy and prognosis	—

Contacts

Public ContactKei Saito

Nihon University School of Medicine

saito.kei@nihon-u.ac.jp+81-3-3972-8111

Outcome results